<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891432</url>
  </required_header>
  <id_info>
    <org_study_id>2101-142-1191</org_study_id>
    <nct_id>NCT04891432</nct_id>
  </id_info>
  <brief_title>Comparison of Surgical Outcomes Between Pre Sympathetic Plexus and Post Sympathetic Plexus Approach</brief_title>
  <official_title>Comparison of Surgical Outcomes Between Pre Sympathetic Plexus and Post Sympathetic Plexus Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      There would be no difference in the risk of sympathetic plexus damage between the pre&#xD;
      sympathetic plexus approach and the post sympathetic plexus approach.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compare the incidence of sympathetic chain injury between front and back of sympathetic&#xD;
      approach in oblique lumbar interbody fusion&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>The rate of sympathetic plexus injury</measure>
    <time_frame>Postoperative day one</time_frame>
    <description>Edema of the lower extremity, change of skin temperature, pain, or paresthesia without other medical conditions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other complications</measure>
    <time_frame>Postoperative 6 month</time_frame>
    <description>Injury of vascular structure, ureter, peritoneum, or bowel.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Fusion of Spine, Lumbosacral Region</condition>
  <condition>Sympathetic Nervous System</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lateral lumbar interbody fusion</intervention_name>
    <description>oblique lumbar interbody fusion or direct lateral interbody fusion</description>
    <other_name>front versus back sympathetic chain approach</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with lumbar degenerative disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with lumbar degenerative disease needs a lateral lumbar interbody fusion of&#xD;
             1-2 segments between L2 to S1.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who had previously had lumbar surgery&#xD;
&#xD;
          -  Patients with muscle weakness of motor grade III or lower&#xD;
&#xD;
          -  Patients with neuropsychiatric diseases such as depression&#xD;
&#xD;
          -  Patients with musculoskeletal disease, inflammatory musculoskeletal disease, or&#xD;
             infection&#xD;
&#xD;
          -  Patients with cancerous disease&#xD;
&#xD;
          -  Patients who do not want to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chi Heon Kim, MD</last_name>
    <phone>+82-2-2072-3398</phone>
    <email>chiheon1@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Korea</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seoul National U Hospital</last_name>
      <phone>22072358</phone>
      <email>chiheon1@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 13, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Chi Heon Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

